Approval
Genentech Receives Additional Approval for Tecentriq
Emilie Branch
Pharma's Almanac
PAO-M12-18-NI-011Dec 11, 2018
FDA Approval
Genentech Receives FDA Approval for Flu Medicine
Pharma's Almanac
PAO-M11-18-NI-001Nov 05, 2018
Phase II Results
Promising Phase 2 Results for Eye Implant from Genentech
Nice Insight
PAO-M08-18-NI-003Jul 31, 2018
Study Results
Phase III IMpower130 Study Showed Genentech’s TECENTRIQ (Atezolizumab) Plus Chemotherapy (Carboplatin and ABRAXANE) Helped Against Lung Cancer
Genentech
PR-M05-18-NI-116May 31, 2018
Clinical Trials
Genentech Provides Update on Phase III Study of TECENTRIQ (Atezolizumab) and COTELLIC (Cobimetinib)
Genentech
PR-M05-18-NI-048May 14, 2018
FDA Approval
Advanced Follicular Lymphoma Treatment Approved
Nice Insight
PAO-M11-17-NI-048Nov 28, 2017
Biosimilar
FDA Approves First Biosimilar Treatment for Multiple Cancers
Emilie Branch
Pharma's Almanac
PAO-M09-17-NI-030Sep 26, 2017